ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Metastatic clear cell renal cell carcinomas (ccRCCs) are resistant to DNA-damaging chemotherapies, limiting therapeutic options for patients whose tumors are resistant to tyrosine kinase inhibitors and/or immune checkpoint therapies. Here we show that mouse and human ccRCCs were frequently character...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
American Society for Clinical investigation
2022-12-01
|
丛编: | JCI Insight |
主题: | |
在线阅读: | https://doi.org/10.1172/jci.insight.156087 |